1.Global structure of HIV-1 neutralizing antibody IgG1 b12 isasymmetric. Ashish, Solanki AK, Boone CD, Krueger JK (BBRC, 2010)
2. SAXS data analysis and modeling of tetravalent neutralizing antibodyCD4-IgG2 -/+ HIV-1 gp120 revealed that first two gp120 bind to the same Fabarm. Rathore YS, Solanki AK, Dhoke RR, Ashish (BBRC, 2011)
3. Evidence on how a conserved glycine in the hinge region of Hapr regulatesits DNA binding ability: lessons from a natural variant. Dongre M, Singh NS, Dureja C, Peddada N, Solanki AK, Ashish,Raychaudhuri S ( JBC, 2011)
4. Visualizing the elusive open shape of G-actin in solution by SAXS data analysis. Sagar A, Peddada N, Solanki AK, Choudhary V, Garg R., Ashish (BBRC, 2013)
5. Carrier protein influences immunodominance hierarchy: implication invaccine design. Ghosh M, Solanki AK, Roy K, Dhoke RR, Ashish and Syamal Roy (Vaccine,2013)
6. Global shape and ligand binding efficiency of the HIV-1 neutralizingantibodies differs from the ones which cannot neutralize. Solanki AK, Rathore YS, Badmalia MB, Dhoke RR, Nath SK, Nihalani D and Ashish (JBC,2014)
7. Adriamycin susceptibility among C57BL/6 substrains. Arif E, Solanki AK and Nihalani D (Kid. International, 2016)
8. Structural analysis of the Myo1c and Neph1 complex provides insight intothe intracellular movement of Neph1. Arif E, Sharma P, Solanki AK, Mallik L, Rathore YS, Twal WO, NathSK, Gandhi D, Holzman LB, Ostap M, Ashish, Nihalani D (Mol. Cell Biol., 2016)
9. Targeting Neph1 and ZO-1 protein-protein interaction in podocytesprevents podocyte injury and preserves glomerular filtration function. ArifE, Sagar A, Solanki AK, Srivastava P, Nihalani D and Ashish (ScientificReports, 2017)
10. A novel mutation in CLCN5 linked with Dent’s disease is associated withFSGS and podocyte injury. Solanki AK, Arif E, Srivastava P, Dang P, Milos B, Janech M. G., Nihalani D (Kid.International Rep., 2018)
11. Development of a novel cell-based assay to diagnose recurrent Focal andSegmental Glomerulosclerosis Srivastava P*, Solanki AK*, Arif E, Dang P, Milos B, JanechM. G., Nihalani D (Kid. International, 2018, *Equal author)
12.Mitochondrial biogenesis induced by the β2-adrenergic receptor agonistformoterol accelerates podocyte recovery from acute injury Arif E, Solanki AK, Srivastava P, Rahman B, Fitzgibbon WR, Deng P, Budisavljevic Milos N, Catalin F Baicu,Michael R Zile, Megyesi J, Janech MG, Kwon SH, Justin Collier, Rick GSchnellmann, Deepak Nihalani (Kid. International, 2019)
13. The motor protein Myo1c regulates transforming growth factor-β-signalingand fibrosis in podocytes ArifE, Solanki AK, Srivastava P, Rahman B, Tash BR, Holzman LB, Janech MG,Martin R, Knölker H, Fitzgibbon WR, Deng P, Budisavljevic MN, Syn WK, Wang C,Lipschutz JH, Kwon SH, Nihalani D (Kid. International, 2019)
14. Disruptionof the exocyst induces podocyte loss and dysfunction. Nihalani D*, SolankiAK*, Arif E, Srivastava P, Rahman B, Zuo X, Dang Y, Fogelgren B, D Fermin D, Gillies CE, Sampson M, Lipschutz JH (JBC, 2019, *Equal Author)
15. Mutations in KIRREL1 a slit diaphragm component cause steroid-resistantnephrotic syndrome Solanki AK, Widmeier E , Arif E, Sharma S, Daga A, Srivastava P, Kwon SH, Hugo H,Nakayama M, Nina M, Mujumdar A, Wei Tan2, Heon Yung Gee2,4, Sadowski C, RinatC, Cohen RB, Bergmann C, Rosen S, Somers M, Shril S, Huber TB, Mane S,Hildebrandt FH, Nihalani D (Kid. International, 2019)
16.The use of high-throughputtranscriptomics to identify pathways with therapeutical significance in podocytesSolanki AK, Srivastava P, Rahman B, Lipschutz JH, Nihalani D, ArifEhtesham (International Journal of MolecularSciences, 2019)
17. Importance of an essentialligand-binding domain in the vitamin A transporter Rbpr2 for proper eyedevelopment and photoreceptor cell survival Solanki AK, Kondkar AA, Su Y, Rohrer B, Lipschutz JH, Nihalani D, and Lobo GP (Cells, 2020)